ArticleInflammopharmacology2025

Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington's disease: modulation of angiotensin and CREB/BDNF/PGC1-α signaling.

Ali M Elgindy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.